Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Italy
  4. Borsa Italiana
  5. Recordati
  6. News
  7. Summary
    REC   IT0003828271

RECORDATI

(REC)
  Report
Delayed Borsa Italiana  -  11:35 2022-06-24 am EDT
41.86 EUR   +7.64%
06/20RECORDATI : Share buy-back program to service the stock option plans
PU
06/14RECORDATI : Ultima presentazione del gruppo
PU
06/14RECORDATI : Latest Company presentation
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Transcript : Recordati Industria Chimica e Farmaceutica S.p.A., Q1 2022 Earnings Call, May 10, 2022

05/10/2022 | 10:00am EDT
share with twitter
share with LinkedIn
share with facebook
Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the Recordati conference call. [Operator Instructions] At this time, I would like to turn the...


© S&P Capital IQ 2022
All news about RECORDATI
06/20RECORDATI : Share buy-back program to service the stock option plans
PU
06/14RECORDATI : Ultima presentazione del gruppo
PU
06/14RECORDATI : Latest Company presentation
PU
05/23RECORDATI : Ex-dividend day for final dividend
FA
05/18Alliance Pharma Chair to Step Down in 2023; Successor Named
MT
05/10Recordati Industria Chimica e Farmaceutica S.p.A. Reports Earnings Results for the Firs..
CI
05/10Recordati Industria Chimica Seeks M&A
CI
05/10TRANSCRIPT : Recordati Industria Chimica e Farmaceutica S.p.A., Q1 2022 Earnings Call, May..
CI
05/10Recordati Confirms 2022 Financial Targets
MT
05/10Recordati confirms 2022 targets despite Ukraine conflict
RE
More news
Analyst Recommendations on RECORDATI
More recommendations
Financials
Sales 2022 1 755 M 1 852 M 1 852 M
Net income 2022 383 M 404 M 404 M
Net Debt 2022 1 366 M 1 441 M 1 441 M
P/E ratio 2022 23,6x
Yield 2022 2,67%
Capitalization 8 606 M 9 078 M 9 078 M
EV / Sales 2022 5,68x
EV / Sales 2023 5,16x
Nbr of Employees 4 303
Free-Float 46,5%
Chart RECORDATI
Duration : Period :
Recordati Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RECORDATI
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 41,86 €
Average target price 46,38 €
Spread / Average Target 10,8%
EPS Revisions
Managers and Directors
Robert Koremans Chief Executive Officer
Luigi Felice la Corte Group Chief Financial Officer
Andrea Recordati Chairman
Raffaele Sabia Senior VP-Pharmaceutical Research & Development
Giovanni Minora Head-Group Audit & Compliance
Sector and Competitors
1st jan.Capi. (M$)
RECORDATI-25.91%9 078
JOHNSON & JOHNSON5.02%479 678
ELI LILLY AND COMPANY13.21%293 110
PFIZER, INC.-15.17%289 466
ROCHE HOLDING AG-15.91%272 090
ABBVIE INC.12.51%269 202